American Chemical Society - 229th National Meeting. Carbohydrate vaccines: 13-17 March 2005, San Diego, CA, USA

Research output: Contribution to journalArticle

Abstract

The field of synthetic antibodies is an area that should be continually monitored. Pivotal clinical trials are underway with cancer vaccines, and synthetic HIV vaccines are moving into advanced preclinical studies. Cost issues are being addressed in an attempt to make the products affordable in poor countries where these vaccines are urgently needed.

Original languageEnglish
Pages (from-to)387-389
Number of pages3
JournalIDrugs
Volume8
Issue number5
StatePublished - 1 May 2005

Fingerprint

AIDS Vaccines
Cancer Vaccines
Synthetic Vaccines
Vaccines
Carbohydrates
Clinical Trials
Costs and Cost Analysis
Antibodies

Cite this

@article{2860ede0aab54c829e7ae8e734cb7402,
title = "American Chemical Society - 229th National Meeting. Carbohydrate vaccines: 13-17 March 2005, San Diego, CA, USA",
abstract = "The field of synthetic antibodies is an area that should be continually monitored. Pivotal clinical trials are underway with cancer vaccines, and synthetic HIV vaccines are moving into advanced preclinical studies. Cost issues are being addressed in an attempt to make the products affordable in poor countries where these vaccines are urgently needed.",
author = "David Rotella",
year = "2005",
month = "5",
day = "1",
language = "English",
volume = "8",
pages = "387--389",
journal = "IDrugs",
issn = "1369-7056",
publisher = "Current Drugs Ltd.",
number = "5",

}

American Chemical Society - 229th National Meeting. Carbohydrate vaccines : 13-17 March 2005, San Diego, CA, USA. / Rotella, David.

In: IDrugs, Vol. 8, No. 5, 01.05.2005, p. 387-389.

Research output: Contribution to journalArticle

TY - JOUR

T1 - American Chemical Society - 229th National Meeting. Carbohydrate vaccines

T2 - 13-17 March 2005, San Diego, CA, USA

AU - Rotella, David

PY - 2005/5/1

Y1 - 2005/5/1

N2 - The field of synthetic antibodies is an area that should be continually monitored. Pivotal clinical trials are underway with cancer vaccines, and synthetic HIV vaccines are moving into advanced preclinical studies. Cost issues are being addressed in an attempt to make the products affordable in poor countries where these vaccines are urgently needed.

AB - The field of synthetic antibodies is an area that should be continually monitored. Pivotal clinical trials are underway with cancer vaccines, and synthetic HIV vaccines are moving into advanced preclinical studies. Cost issues are being addressed in an attempt to make the products affordable in poor countries where these vaccines are urgently needed.

UR - http://www.scopus.com/inward/record.url?scp=18144430284&partnerID=8YFLogxK

M3 - Article

C2 - 15883917

AN - SCOPUS:18144430284

VL - 8

SP - 387

EP - 389

JO - IDrugs

JF - IDrugs

SN - 1369-7056

IS - 5

ER -